NLNK - ニュ―リンク・ジェネティクス (NewLink Genetics Corporation) ニュ―リンク・ジェネティクス

 NLNKのチャート


 NLNKの企業情報

symbol NLNK
会社名 NewLink Genetics Corp (ニュ―リンク・ジェネティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ニューリンク・ジェネティクス(NewLink Genetics Corporation)は、癌治療用免疫療法製品の発見・開発・実用化に焦点を当てる臨床病期の免疫腫瘍学会社である。同社のポートフォリオは、一連の腫瘍学的適応症のための生物学的及び小分子免疫療法剤候補を含む。同社の生物学的製品候補は、ヒト免疫系を刺激して癌細胞を攻撃するように設計されたHyperAcute細胞免疫療法技術に基づく。臨床開発中のHyperAcute細胞免疫療法製品の追加候補には、進行性肺癌および黒色腫患者のためのtergenpumatucel-Lおよびdorgenmeltucel-Lがそれぞれ含まれる。同社のGDC-0919とインドキシモードの2つの小分子製品の候補が臨床開発段階にある。これらの製品候補は、インドールアミン-2 3-ジオキシゲナーゼ(IDO)経路阻害剤であり、免疫系の癌に対する耐性を破壊することに焦点を当てる。   ニュ―リンク・ジェネティクスは米国のバイオ医薬品会社。がん治療に使用される生物製剤と小分子免疫療法製品の開発と商業化に従事。患者の免疫システムを高めるように設計されている、独自の「ハイパ―アキュ―ト」技術に基づく治療薬の開発に重点を置く。本社はアイオワ州。   NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA.
本社所在地 2503 South Loop Drive Ames IA 50010 USA
代表者氏名 Charles J. Link チャールズJ.リンク
代表者役職名 Chairman of the Board Chief Executive Officer Chief Scientific Officer
電話番号 +1 515-296-5555
設立年月日 36312
市場名 NASDAQ National Market System
ipoyear 2011年
従業員数 76人
url www.newlinkgenetics.com
nasdaq_url https://www.nasdaq.com/symbol/nlnk
adr_tso
EBITDA EBITDA(百万ドル) -70.07300
終値(lastsale) 2.32
時価総額(marketcap) 86337143.52
時価総額 時価総額(百万ドル) 81.87143
売上高 売上高(百万ドル) 27.73200
企業価値(EV) 企業価値(EV)(百万ドル) -55.02757
当期純利益 当期純利益(百万ドル) -69.93500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NewLink Genetics Corp revenues decreased 7% to $12.2M. Net loss decreased 5% to $35.6M. Revenues reflect Grant Revenue decrease of 13% to $11.3M. Lower net loss reflects Research and development decrease of 4% to $32.4M (expense) General and administrative decrease of 5% to $16.2M (expense) Interest Income increase from $202K to $846K (income).

 NLNKのテクニカル分析


 NLNKのニュース

   NewLink shareholders back Lumos merger  2020/03/18 12:16:57 Seeking Alpha
NewLink Genetics (NASDAQ:NLNK) shareholders have voted overwhelmingly in favor of its previously announced merger with Lumos Pharma. The combined company w
   NewLink (NLNK) to Report Q4 Earnings: What's in the Cards?  2020/02/18 07:41:00 Zacks Investment Research
Investors are looking forward to updates on NewLink's (NLNK) merger with Lumos Pharma, when the former releases fourth-quarter 2019 results.
   The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares  2019/12/26 12:55:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 24.) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) DURECT Corporation (NASDAQ: DRRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Exagen Inc (NASDAQ: XGN ) Forty Seven Inc (NASDAQ: FTSV ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Harpoon Therapeutics Inc (NASDAQ: HARP ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Kodiak Sciences Inc (NASDAQ: KOD ) (JPMorgan initiated coverage with an Outperform rating) Microbot Medical Inc (NASDAQ: MBOT ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc.
   Why This Ovarian Cancer Drug Could Be Huge for NewLink Genetics  2019/12/24 14:40:36 24/7 Wall street
   The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict  2019/12/24 12:24:51 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 23)
   NewLink shareholders back Lumos merger  2020/03/18 12:16:57 Seeking Alpha
NewLink Genetics (NASDAQ:NLNK) shareholders have voted overwhelmingly in favor of its previously announced merger with Lumos Pharma. The combined company w
   NewLink (NLNK) to Report Q4 Earnings: What's in the Cards?  2020/02/18 07:41:00 Zacks Investment Research
Investors are looking forward to updates on NewLink's (NLNK) merger with Lumos Pharma, when the former releases fourth-quarter 2019 results.
   The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares  2019/12/26 12:55:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 24.) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) DURECT Corporation (NASDAQ: DRRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Exagen Inc (NASDAQ: XGN ) Forty Seven Inc (NASDAQ: FTSV ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Harpoon Therapeutics Inc (NASDAQ: HARP ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Kodiak Sciences Inc (NASDAQ: KOD ) (JPMorgan initiated coverage with an Outperform rating) Microbot Medical Inc (NASDAQ: MBOT ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc.
   Why This Ovarian Cancer Drug Could Be Huge for NewLink Genetics  2019/12/24 14:40:36 24/7 Wall street
   The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict  2019/12/24 12:24:51 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 23)
   NewLink shareholders back Lumos merger  2020/03/18 12:16:57 Seeking Alpha
NewLink Genetics (NASDAQ:NLNK) shareholders have voted overwhelmingly in favor of its previously announced merger with Lumos Pharma. The combined company w
   NewLink (NLNK) to Report Q4 Earnings: What's in the Cards?  2020/02/18 07:41:00 Zacks Investment Research
Investors are looking forward to updates on NewLink's (NLNK) merger with Lumos Pharma, when the former releases fourth-quarter 2019 results.
   The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares  2019/12/26 12:55:50 Benzinga
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 24.) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Applied Genetic Technologies Corp (NASDAQ: AGTC ) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearside Biomedical Inc (NASDAQ: CLSD ) DURECT Corporation (NASDAQ: DRRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Exagen Inc (NASDAQ: XGN ) Forty Seven Inc (NASDAQ: FTSV ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Global Blood Therapeutics Inc (NASDAQ: GBT ) Harpoon Therapeutics Inc (NASDAQ: HARP ) Horizon Therapeutics PLC (NASDAQ: HZNP ) HEALTH SCIENCES/SH (NASDAQ: IMVT ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Karyopharm Therapeutics Inc (NASDAQ: KPTI ) Kodiak Sciences Inc (NASDAQ: KOD ) (JPMorgan initiated coverage with an Outperform rating) Microbot Medical Inc (NASDAQ: MBOT ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Momenta Pharmaceuticals, Inc.
   Why This Ovarian Cancer Drug Could Be Huge for NewLink Genetics  2019/12/24 14:40:36 24/7 Wall street
   The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict  2019/12/24 12:24:51 Benzinga Feeds
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 23)

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ニュ―リンク・ジェネティクス NLNK NewLink Genetics Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)